NCT00000371View on ClinicalTrials.gov

Trial of D-Cycloserine in Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 1996

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
Schizophrenia
Interventions
DRUG

D-cycloserine

50 mg/daily by mouth

DRUG

Placebo

50 mg/day of placebo by mouth

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00000371 - Trial of D-Cycloserine in Schizophrenia | Biotech Hunter | Biotech Hunter